Related references
Note: Only part of the references are listed.Artificial intelligence in digital breast pathology: Techniques and applications
Asmaa Ibrahim et al.
BREAST (2020)
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring et al.
CLINICAL CANCER RESEARCH (2020)
A Multi-Organ Nucleus Segmentation Challenge
Neeraj Kumar et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2020)
Biomedical image augmentation using Augmentor
Marcus D. Bloice et al.
BIOINFORMATICS (2019)
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
Alessandra Landmann et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+Subtypes
Brittany L. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Makoto Asano et al.
ANTICANCER RESEARCH (2018)
Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER plus breast cancer
Jon Whitney et al.
BMC CANCER (2018)
Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers
Cheng Lu et al.
LABORATORY INVESTIGATION (2018)
A Dataset and a Technique for Generalized Nuclear Segmentation for Computational Pathology
Neeraj Kumar et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2017)
The Digital Slide Archive: A Software Platform for Management, Integration, and Analysis of Histology for Cancer Research
David A. Gutman et al.
CANCER RESEARCH (2017)
BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis
Thalia Erbes et al.
CLINICAL BREAST CANCER (2016)
Structure-Preserving Color Normalization and Sparse Stain Separation for Histological Images
Abhishek Vahadane et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2016)
Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Yoon Yang Jung et al.
JOURNAL OF BREAST CANCER (2016)
Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER plus Breast Cancer Whole Slide Images
David Romo-Bucheli et al.
SCIENTIFIC REPORTS (2016)
Gray-Level Co-Occurrence Matrix Texture Analysis of Breast Tumor Images in Prognosis of Distant Metastasis Risk
Tijana Vujasinovic et al.
MICROSCOPY AND MICROANALYSIS (2015)
New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images
Jia-Mei Chen et al.
SCIENTIFIC REPORTS (2015)
Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Beyhan Ataseven et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Current and future role of neoadjuvant therapy for breast cancer
Michael Untch et al.
BREAST (2014)
Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Kwan Il Kim et al.
JOURNAL OF BREAST CANCER (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
Jyothi S. Prabhu et al.
JOURNAL OF CANCER (2014)
Mitosis detection in breast cancer pathology images by combining handcrafted and convolutional neural network features
Haibo Wang et al.
JOURNAL OF MEDICAL IMAGING (2014)
Nonlinear Optical Microscopy Signal Processing Strategies in Cancer
Javier Adur et al.
CANCER INFORMATICS (2014)
Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer
Nobuaki Matsubara et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Morphologic Features Do Not Influence Response to Trastuzumab-containing Neoadjuvant Chemotherapy in HER2-positive Breast Cancer
Xin Li et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2013)
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
Makiko Ono et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer
Mitko Veta et al.
MODERN PATHOLOGY (2012)
Predictors of Pathologic Complete Response After Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma
James A. Kraus et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
